Enzase 25000 Capsule contains Pancreatin 300 mg, a combination of digestive enzymes including amylase, lipase, and protease, which aid in the breakdown of carbohydrates, fats, and proteins respectively. This medication is indicated for patients with pancreatic exocrine insufficiency resulting from conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or other disorders causing impaired pancreatic enzyme production. By supplementing endogenous enzymes, Enzase 25000 facilitates improved digestion and nutrient absorption, thereby alleviating symptoms like steatorrhea, malnutrition, and weight loss. The recommended dosage varies depending on the severity of enzyme deficiency and dietary fat intake, and should be individualized by a healthcare professional. Enzase 25000 is generally well tolerated; however, potential adverse effects may include gastrointestinal disturbances such as nausea, abdominal pain, or allergic reactions in rare cases. It is contraindicated in patients with hypersensitivity to pancreatin or any component of the formulation. Caution is advised in patients with acute pancreatitis or pancreatic carcinoma. Enzase 25000 should be taken with meals or snacks to optimize enzyme activity. Regular monitoring of clinical response and nutritional status is essential to ensure therapeutic efficacy and adjust dosing accordingly. This product should be stored in a cool, dry place, away from direct sunlight.